EMAPALUMAB-LZSG | B761107 | NOVIMMUNE S.A.
Regulatory Exclusivities
| Type | Expiry | Status | Source |
|---|---|---|---|
| 12-Year BPCIA | Nov. 20, 2030 | Active | Computed |
| 7-Year Orphan | Nov. 20, 2025 | Expired | Purple Book |
Purple Book Patents
No listed patents in Purple Book.
Estimated Patent LOE
Based on latest discovered patent 12037389(method of use) · relevance 94/100
Estimate based on AI-discovered patents. No patents are officially listed in the Purple Book for this product.
4 AI-discovered patents, sorted by relevance.
No patent or exclusivity listings for this strength.